1 or transplant and waitlist mortality in this
pilot study.
2 nstrate initial feasibility in an 11-subject
pilot study.
3 MFB-DBS were demonstrated as in our previous
pilot study.
4 meostasis and improved colitis symptoms in a
pilot study.
5 n haemagglutination inhibition titres from a
pilot study.
6 omparable to bulk cellular hydrogels in this
pilot study.
7 Prospective, randomized,
pilot study.
8 with the tumor response on pathology in this
pilot study.
9 Single-center, prospective, randomized,
pilot study.
10 acter-like" process causes PC justified this
pilot study.
11 rates have recently been reported in a small
pilot study.
12 families were recruited to participate in a
pilot study.
13 nted as means +/- standard deviation in this
pilot study.
14 with the tumor response on pathology in this
pilot study.
15 nt to FA, detected DR reliably in this small
pilot study.
16 ore and during antiangiogenic treatment in a
pilot study.
17 A-compliant, single-institution, prospective
pilot study.
18 e and safe as PKE + NPDS at 9 months in this
pilot study.
19 s were imported from the ACS NSQIP geriatric
pilot study.
20 d in a prospective single-center, open-label
pilot study.
21 cell disease in a single-center, open-label
pilot study.
22 y between these factors and AD severity in a
pilot study.
23 e and facilitated by continuous learning and
pilot studies.
24 95% CI, 41.3%-42.9%) than predicted based on
pilot studies.
25 ion of investigators, and perform innovative
pilot studies.
26 Pilot study 1 included 22 adults randomly assigned to pl
27 stered at clinicaltrials.gov as NCT00552409 (
pilot study 1) and NCT01477034 (pilot study 2).
28 d, retrospective, comparative, single-center
pilot study,
105 consecutive eyes of 75 patients with un
29 For this
pilot study,
16 patients with early AD and 17 healthy ag
30 bo-controlled, single-blind, dose-escalation
pilot study,
18 subjects with perennial allergic rhiniti
31 Pilot study 2 included 15 adults randomly assigned to 20
32 NCT00552409 (pilot study 1) and NCT01477034 (
pilot study 2).
33 In an observational
pilot study,
28 lung transplant recipients were enrolled
34 Of 97 people recruited to the
pilot study,
51 were randomly allocated to the control g
35 In this preclinical
pilot study,
a novel anti-inflammatory approach was eval
36 In this
pilot study,
acute dietary NO3 (-) intake was well toler
37 abel, single-arm, multicenter, international
pilot study,
adults with recent HCV (duration of infecti
38 The current
pilot study aimed to develop and test a range of scales
39 This
pilot study aimed to investigate the feasibility of rege
40 This
pilot study aims to evaluate cerebral blood flow (CBF) a
41 In this
pilot study,
all patients from a specific mountain regio
42 In the
pilot study,
all subjects had PSL and fluorescent tracer
43 c utility of tau368 was first evaluated in a
pilot study (
Alzheimer's disease = 20, control = 20), th
44 BACKGROUND & AIMS: After careful
pilot studies and planning, the national screening progr
45 After careful
pilot studies and planning, the national screening progr
46 e respiratory distress syndrome therapies in
pilot studies and potentially reduce the frequency of fa
47 d ongoing studies including abstracts, small
pilot studies and protocols to forecast future direction
48 A subgroup (n = 1,127 from a
pilot study and 1,045 from the present study) was identi
49 s undertaken in 22 countries to complement a
pilot study and provide novel information on medication
50 Pilot studies are evaluating the efficacy of dual therap
51 The results of this
pilot study are discussed in light of the present litera
52 Limitations of this
pilot study are the small sample size, inclusion of part
53 In this
pilot study,
AS leads to abnormal blood flow pattern and
54 This multicenter
pilot study assessed the safety and efficacy of brentuxi
55 local heart teams were enrolled in a global
pilot study at 14 sites (United States, Australia, and E
56 ndomized controlled trial was conducted as a
pilot study at a tertiary referral medical center.
57 Clinical and correlative
pilot study at the National Institutes of Health Clinica
58 enrolled at seven of the 34 sites during the
pilot study between Jan 15, 2014, and April 10, 2014.
59 In a translational
pilot study,
blood samples were obtained from human subj
60 n directly compared with (68)Ga-PSMA-11 in a
pilot study but indeed identified additional PSMA-avid s
61 s and Methods This prospective study (Verona
Pilot Study,
clinical trial identification: 2015/1238) i
62 A model was developed using a
pilot study cohort (n = 290) and a retrospective patient
63 In this
pilot study coined the "Truth Fairy" Project, 50 shed de
64 A
pilot study commenced in May 2004, followed by multicent
65 This prospective, multicenter, randomized,
pilot study compared outcomes in LVAD patients using an
66 This pre-post educational intervention
pilot study compared the gains in teamwork skills for mi
67 This
pilot study compares symptoms of depression and risk fac
68 onor, we performed a prospective multicenter
pilot study comparing HIV D+/R+ vs HIV-negative donor to
69 Randomized, double-blind, placebo-controlled
pilot study conducted from January 5, 2009, to March 27,
70 In this
pilot study consisting of patients who initiated cART du
71 Pilot studies demonstrated endogenous field-dependant co
72 Conclusion: This
pilot study demonstrated DPSMA uptake and kinetics in lo
73 Conclusion Results of this
pilot study demonstrated the feasibility of luminal wate
74 Taken together, this
pilot study demonstrated the feasibility of precised pre
75 A prior
pilot study demonstrated the systemic absorption of 4 su
76 This
pilot study demonstrates high rates of symptoms of depre
77 This
pilot study demonstrates that a restrictive resuscitatio
78 This
pilot study demonstrates that intradialytic cerebral isc
79 This
pilot study demonstrates that longer timeframes are requ
80 This
pilot study demonstrates that non-mucinous PM of CRC can
81 This
pilot study demonstrates the ability of the newly develo
82 This
pilot study demonstrates the potential of metabolic biom
83 This
pilot study demonstrates the utility, safety, and feasib
84 Although this
pilot study did not control for the differential contrib
85 In this multicenter
pilot study directly comparing HIV D+/R+ with HIV D-/R+
86 Results from the
pilot studies enabled improvements after each pilot test
87 This prospective, observational
pilot study enrolled neonatal deaths at Chris Hani Barag
88 This prospective, multicentric, uncontrolled
pilot study enrolled patients with compensated cirrhosis
89 This prospective
pilot study evaluated the ability of Na(18)F PET/CT to d
90 gate this multifaceted relationship, a human
pilot study examined cortisol concentration in sweat and
91 The current
pilot study examined interoceptive processing in childre
92 This
pilot study examines the correlation of X-ray diffractio
93 ention types, many were small feasibility or
pilot studies,
few studies reported effect sizes and no
94 In this proof-of-principle open-label
pilot study,
five individuals with stroke received 10 se
95 In this
pilot study,
for the first time, we evaluated various se
96 Finally, a clinical
pilot study (
German clinical trial number DRKS00009253)
97 Two groups were analyzed for this
pilot study:
Group 1 was composed of IRD two with autoso
98 have been implicated in CA pathogenesis, and
pilot study had suggested potential microbiome differenc
99 A
pilot study has been performed to analyze clinical blood
100 Pilot studies have hinted that serotonergic psychedelics
101 These
pilot studies have suggested that adaptive deep brain st
102 In a
pilot study,
heavy water labeling was used to determine
103 This
pilot study highlights the utility of molecular intragra
104 s part of the larger HIV Organ Policy Equity
pilot study,
HIV-positive to HIV-positive kidney and liv
105 In this small
pilot study,
HuCNS-SC transplantation seems to be associ
106 This
pilot study identifies several novel candidate driver mu
107 This
pilot study illustrates how UAS can be used to conduct r
108 This
pilot study illustrates the potential of FFC relaxometry
109 Human
pilot studies in breast cancer and melanoma patients usi
110 Procedures were developed and implemented in
pilot studies in five organizations.
111 Limited data from
pilot studies in patients with CKD stages 3-4 suggest th
112 We now describe
pilot studies in women.
113 Results: The
pilot study in 10 patients who were examined with both P
114 sunset in metabolic syndrome, we conducted a
pilot study in 14 subjects with metabolic syndrome who f
115 We tested MASQ in a
pilot study in acute myeloid leukemia (AML) patients who
116 This
pilot study in healthy volunteers demonstrates the feasi
117 indings, a moderate high-salt challenge in a
pilot study in humans reduced intestinal survival of Lac
118 s shown promise in preclinical studies and a
pilot study in intermediate AMD (iAMD) as a potential tr
119 This
pilot study in lung transplant recipients suggests that
120 ulticenter prospective randomized controlled
pilot study in patients with tetralogy of Fallot aged 10
121 In a
pilot study in the third cohort, gametocyte clearance fo
122 Here we conducted a
pilot study in which infants delivered by C-section were
123 y volunteers (7F/5M) completed an open-label
pilot study including assessments 1-day before, 1-week a
124 This
pilot study indicated using laser irradiation during per
125 This
pilot study,
integrating clinical and molecular-based te
126 This
pilot study investigated the effect of exercise on plasm
127 This
pilot study investigated the nutrigenomic pathways by wh
128 simulated based on the characteristics of a
pilot study investigating a given biomedical issue.
129 We present the results of an ex vivo
pilot study involving 10 cases of biopsy-proven sarcoma
130 The aim of this
pilot study is to describe the early safety and efficacy
131 In a previous
pilot study,
L-T4 treatment reduced depression scores an
132 In the
pilot study,
left-over blood gas syringes were collected
133 In a
pilot study,
LFS patients treated with metformin exhibit
134 Thus, our
pilot study may provide important information about the
135 In this small
pilot study,
methylphenidate treatment was associated wi
136 We conducted a
pilot study (
n = 10) using plasma from age- and sex-matc
137 In a
pilot study (
n = 266), the blood methylation levels of 3
138 ionnaire, and (3) final evaluation through a
pilot study (
n = 93) with test-retest evaluation (n = 50
139 ral Regurgitation - The Twelve Intrepid TMVR
Pilot Study;
NCT02322840).
140 nor compensation should be modified to allow
pilot studies of financial incentives for living kidney
141 We operationalize the typology in
pilot studies of SDG strategies undertaken in Senegal, C
142 In a
pilot study of 12 healthy subjects aged between 25 and 6
143 n in PD and unaffected controls to conduct a
pilot study of 192 subjects from the LRRK2 Cohort Consor
144 The Sarcolab
pilot study of 2 crewmembers, investigated before and af
145 In this
pilot study of 20 neurosurgical patients without glaucom
146 nt changes in retinal microvasculature, in a
pilot study of 55 pediatric T1D patients from Singapore
147 We conducted a
pilot study of a promising drug to treat diffuse axonal
148 To conduct a proof-of-concept
pilot study of a wireless, patient-centered outcomes mon
149 bit Restenosis and Maintain Vessel Patency-A
Pilot Study of Anti-Restenosis Treatment) was a multicen
150 A
pilot study of fucosylation in liver cirrhosis of the HC
151 In this randomized
pilot study of LVAD patient management we demonstrated t
152 stinal dysfunction in ASD is provided, and a
pilot study of metabolites that can be transferred via f
153 antenatal, intrapartum, and postnatal care (
Pilot study Of midwifery Practice in Preterm birth Inclu
154 We designed a non-randomized, phase 0/1
pilot study of miransertib in adults and children with P
155 2.7-fold with a single oral dose of NR in a
pilot study of one individual, and that oral NR elevates
156 In this
pilot study of patients with nonischemic cardiomyopathy,
157 er-term survival was therefore examined in a
pilot study of posttransplantation survivors.
158 Open-label, single-center, phase 2b
pilot study of previously untreated, noncirrhotic patien
159 double-blind, placebo-controlled, crossover
pilot study of REP supplementation (5 g/day x 4 weeks) w
160 We performed an open-label, single-centre,
pilot study of ruxolitinib in adults with secondary haem
161 In a small, randomized, placebo-controlled
pilot study of schizophrenia, eszopiclone (Lunesta(R)),
162 randomized, double-blind, placebo-controlled
pilot study of simvastatin 80 mg or placebo for 7 days f
163 Here we report on a
pilot study of the Living Root Bridges (LRBs) in the Ind
164 ter regions in the human genome, we report a
pilot study of the methylation profiles of temporal lobe
165 as a double-blind randomized sham controlled
pilot study of transcranial direct current stimulation o
166 clinically evaluable patients enrolled in a
pilot study of uncomplicated SAB, cure rates were 88% fo
167 In
pilot studies on primary clinical specimens, including s
168 In a
pilot study on differentiating early stages of Alzheimer
169 In this
pilot study on umbilical cords post partum from healthy
170 Pilot studies operated by four project partners were vis
171 In this
pilot study patients with FA exhibited a disease-specifi
172 al review board-approved prospective blinded
pilot study,
patients undergoing PCNL provided consent t
173 In this proof-of-concept
pilot study,
patients wore wristband pedometers and comp
174 Here, we report a
pilot study paving the way for further single cell genom
175 In the TRACK-TBI
Pilot study,
plasma was collected at a single time point
176 Our
pilot study points towards aberrations in complement act
177 Results from this
pilot study preliminarily suggest that thermal ablation
178 As a
pilot study,
Pronase E-generated standards from an Abl k
179 In conclusion, our
pilot study provides both an analytical framework and em
180 This
pilot study provides not only proof-of-concept data on t
181 This
pilot study quantified surgeon workload for colorectal p
182 In this
pilot study,
RA patients and age/sex-matched controls we
183 mics on enriched ICs and PCs and performed a
pilot study sequencing four single ICs.
184 probability of benefit in all outcomes, this
pilot study serves as evidence to continue a definitive
185 Pilot studies showed lower tenofovir plasma concentratio
186 An in vivo
pilot study showed a prolonged release of insulin from s
187 Conclusion: This
pilot study showed that both (18)F-PSMA-1007 and (68)Ga-
188 Conclusion This
pilot study showed that decreases in volume and increase
189 This
pilot study showed that PET with [(11) C]FMZ could be a
190 Conclusion: This
pilot study showed the applicability and the potential o
191 This
pilot study shows an independent association between del
192 This
pilot study shows that arteriolar C4d staining is more c
193 The present
pilot study shows that clinical-grade depletion of naive
194 This first-in-human
pilot study shows that molecular imaging using an intrav
195 This
pilot study shows that patients can be stratified accord
196 The evidence from this
pilot study shows that phospholipid metabolism is modula
197 This
pilot study shows that radiomic data before treatment is
198 Our
pilot study shows that the integration of newborn screen
199 Our
pilot study shows the feasibility of using a novel artif
200 Pilot studies suggest that outpatient management followi
201 Pilot studies suggest that ritonavir-boosted darunavir c
202 The main results from this
pilot study suggest that alcohol brief interventions del
203 BTs (P = 0.028).Conclusions: Results of this
pilot study suggest that similar short-term improvements
204 This
pilot study suggests that an additional evaluation of ch
205 This
pilot study suggests that PCP-based skin cancer training
206 The present
pilot study suggests that sc-Met should be further explo
207 This
pilot study suggests that simplified ratio methods such
208 This
pilot study suggests that some patients with HAM have as
209 n of macrolide antibiotics.Conclusions: This
pilot study supports high-dose simvastatin as an adjuvan
210 A prospective, observational, multicenter
pilot study targeting lower risk acute heart failure pat
211 We did a
pilot study testing whether anti-IgE (omalizumab) combin
212 Then, we show in a
pilot study that the biosensor platform successfully dis
213 In this
pilot study the vitamin D concentrations of fortified fo
214 In
pilot studies,
the adjuvant confers potent bactericidal
215 In this
pilot study,
the authors tested whether a single subanes
216 In this
pilot study,
the authors use for the first time a system
217 In this cross-sectional
pilot study,
the effect of e-cig use on biological profi
218 In this
pilot study,
the expression of GR isoforms and MKP-1 cor
219 s: In an Institutional Review Board-approved
pilot study,
the initial clinical utility of PET/CT imag
220 We conclude that, in this
pilot study,
the NGD system provided rapid and accurate
221 statistical significance was not met in this
pilot study:
The mean percentage of positive pixels at M
222 own to induce severe skin toxicity; for this
pilot study,
three patients were included for each inhib
223 We then developed this
pilot study through an iterative collaboration with chur
224 ating research and providing a framework for
pilot studies to assess the feasibility and ethical and
225 We conducted a
pilot study to assess feasibility, on-study retention, t
226 include (1) the development of Corrie, (2) a
pilot study to assess the usability and feasibility of C
227 We performed a
pilot study to assess whether an exercise training progr
228 Using RNA-sequencing, we conducted a
pilot study to better understand the underlying molecula
229 both undergraduate and graduate courses as a
pilot study to determine the feasibility of such softwar
230 We conducted a
pilot study to determine whether these properties would
231 MATERIAL/METHODS: Case-control
pilot study to evaluate nigrosome-1 ex vivo (2 PD, 2 con
232 We performed a prospective
pilot study to evaluate the analysis of methicillin-resi
233 ducted a prospective, randomized, cross-over
pilot study to evaluate the effect of lower dialysate te
234 okine release syndrome (CRS), we conducted a
pilot study to evaluate the safety and feasibility of ad
235 We conducted an open
pilot study to evaluate the safety and potential efficac
236 Therefore, we have performed a
pilot study to examine global transcription and DNA meth
237 To explore this possibility, we conducted a
pilot study to investigate the thyroid disrupting bioact
238 We performed a
pilot study to test the efficacy, safety, and pharmacoki
239 In a compassionate-use
pilot study,
two patients with severe bradykinin-mediate
240 This prospective, observational
pilot study undertook sampling of brain, lung, and liver
241 nnectomic approach for SCC DBS surgery, this
pilot study used the four-bundle tractography 'connectom
242 osclerosis in South Asians Living in America
pilot study using a gas chromatography-tandem mass spect
243 Here, we report a
pilot study using highly sensitive and specific proteomi
244 Our
pilot study using liquid chromatography-mass spectrometr
245 as recently been established and tested in a
pilot study using rodent kidneys.
246 This
pilot study was administered during a 1-year period (Jul
247 This
pilot study was aimed to examine whether nonlinear indic
248 A prospective
pilot study was conducted between July 1 and September 3
249 A
pilot study was conducted for 409 days on PCB impacted s
250 The TRACK-TBI
Pilot study was conducted from April 1, 2010, to June 30
251 A
pilot study was conducted in an opportunistic sample of
252 This
pilot study was conducted to characterize proteomic prof
253 A
pilot study was conducted with samples from immigrants t
254 A
pilot study was conducted, followed by a prospective cas
255 This
pilot study was designed to confirm that staining for SH
256 Aim of the
pilot study was the histologic classification of the inf
257 The goal of this
pilot study was to characterize changes in glutamine met
258 The goal of this
pilot study was to compare multiple methods that estimat
259 The aim of this
pilot study was to determine if metabolic tumor volume (
260 The aim of this
pilot study was to determine the effects of BCAA supplem
261 The goal of this
pilot study was to determine whether HDL glycoprotein co
262 The aim of this
pilot study was to determine whether the CXCR4 ligand (6
263 The purpose of this
pilot study was to evaluate a pay-it-forward strategy to
264 The aim of the
pilot study was to evaluate the effect of Vagus Nerve St
265 The objective of this prospective
pilot study was to examine the effects of a novel non-ph
266 The aim of this
pilot study was to investigate the complementary value o
267 The aim of this
pilot study was to investigate the presence of concurren
268 The primary purpose of this
pilot study was to investigate the timing of palliative
269 The primary objective of this
pilot study was to test the feasibility of delivering an
270 >400 commercially produced seafood species a
pilot study was undertaken to collect and analyse 22 spe
271 In this
pilot study we found that low-volume colon preparation m
272 In this
pilot study,
we addressed the susceptibility of two infa
273 In this
pilot study,
we aim to investigate an ability to optimiz
274 In this
pilot study,
we aimed to identify specific immune mediat
275 In this
pilot study,
we compared the impact of gingival health,
276 In a prospective, multicenter, open-label
pilot study,
we enrolled patients with compensated recur
277 In this
pilot study,
we enrolled sixteen VMT eyes treated with i
278 In this
pilot study,
we evaluated the performance of amplicon se
279 In this
pilot study,
we evaluated whether a novel echocardiograp
280 In this
pilot study,
we examine lung compartment-specific protei
281 In this
pilot study,
we examined the feasibility of using pervas
282 Based on the findings of our
pilot study,
we hypothesize that possible sources of BDE
283 In a
pilot study,
we immunized bats with one of four vaccine
284 In this
pilot study,
we investigated epigenetic patterns in peri
285 In a
pilot study,
we investigated the applicability of the me
286 In this
pilot study,
we longitudinally assessed the frequency an
287 In this cross-sectional
pilot study,
we recruited symptomatic and asymptomatic w
288 In this
pilot study,
we show how multiscale differential dynamic
289 In this
pilot study,
we sought to explore the metabolic profile
290 As a
pilot study,
we use our network to analyze local protein
291 In this
pilot study,
we wanted to investigate whether hen's egg
292 Forty-six participants in the
pilot study were excluded, and 449 of the 455 participan
293 The analyses undertaken in this
pilot study were: moisture, protein, total fat, choleste
294 es (7 cross-sectional, 1 case-control, and 1
pilot study)
were analyzed for classic EDCs (5 studies f
295 ng 17,008 articles, 36 studies, including 10
pilot studies,
were included (n = 5,165 ICU patients).
296 AIMS: To assess in a
pilot study whether (i) Allergy Diary users were able to
297 Our
pilot studies with past influenza viruses identified esc
298 A
pilot study with 5 participants compared skin contaminat
299 In this
pilot study with relatively low patient numbers, we repo
300 We performed an open-label
pilot study with three phases of 2 months each (baseline